Ramael M - Search Results

1

Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC.

Van Der Steen N, Mentens Y, Ramael M, Leon LG, Germonpré P, Ferri J, Gandara DR, Giovannetti E, Peters GJ, Pauwels P, Rolfo C. Van Der Steen N, et al. Among authors: ramael m. Clin Lung Cancer. 2018 Jan;19(1):35-41. doi: 10.1016/j.cllc.2017.06.010. Epub 2017 Jul 6. Clin Lung Cancer. 2018. PMID: 28757336 Review.

2

Immunohistochemical staining of ras oncogene product in neoplastic and non-neoplastic mesothelial tissues: immunoreactivity for N-ras and lack of immunohistochemical staining for Ha-ras and K-ras.

Ramael M, Deblier I, Eerdekens C, Lemmens G, Jacobs W, Van Marck E. Ramael M, et al. J Pathol. 1993 Apr;169(4):421-4. doi: 10.1002/path.1711690406. J Pathol. 1993. PMID: 8501538

3

Detection of numerical chromosomal aberrations in paraffin-embedded malignant pleural mesothelioma by non-isotopic in situ hybridization.

Segers K, Ramael M, Singh SK, Van Daele A, Weyler J, Van Marck E. Segers K, et al. Among authors: ramael m. J Pathol. 1995 Feb;175(2):219-26. doi: 10.1002/path.1711750210. J Pathol. 1995. PMID: 7738718

4

Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma.

Segers K, Backhovens H, Singh SK, De Voecht J, Ramael M, Van Broeckhoven C, Van Marck E. Segers K, et al. Among authors: ramael m. Virchows Arch. 1995;427(4):431-6. doi: 10.1007/BF00199393. Virchows Arch. 1995. PMID: 8548129

5

Glutathione S-transferase expression in malignant mesothelioma and non-neoplastic mesothelium: an immunohistochemical study.

Segers K, Kumar-Singh S, Weyler J, Bogers J, Ramael M, Van Meerbeeck J, Van Marck E. Segers K, et al. Among authors: ramael m. J Cancer Res Clin Oncol. 1996;122(10):619-24. doi: 10.1007/BF01221194. J Cancer Res Clin Oncol. 1996. PMID: 8879260

6

Atypical bronchial carcinoid tumours.

Struyf NJ, Van Meerbeeck JP, Ramael MR, Van Schil PE, Van Marck EA, Vermeire PA. Struyf NJ, et al. Among authors: ramael mr. Respir Med. 1995 Feb;89(2):133-8. doi: 10.1016/0954-6111(95)90196-5. Respir Med. 1995. PMID: 7708998 Free article. No abstract available.

7

Immunoreactivity for the beta chain of the platelet-derived growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.

Ramael M, Buysse C, van den Bossche J, Segers K, van Marck E. Ramael M, et al. J Pathol. 1992 May;167(1):1-4. doi: 10.1002/path.1711670102. J Pathol. 1992. PMID: 1320670

8

Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and in non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1.

Ramael M, van den Bossche J, Buysse C, van Meerbeeck J, Segers K, Vermeire P, van Marck E. Ramael M, et al. J Pathol. 1992 May;167(1):5-8. doi: 10.1002/path.1711670103. J Pathol. 1992. PMID: 1352542

9

Nucleolar organizer regions in mesothelial proliferations.

Ramael M, Van den Bossche J, Buysse C, Van Marck E. Ramael M, et al. J Pathol. 1992 Aug;167(4):435. doi: 10.1002/path.1711670414. J Pathol. 1992. PMID: 1403363 No abstract available.

10

Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium.

Ramael M, Lemmens G, Eerdekens C, Buysse C, Deblier I, Jacobs W, van Marck E. Ramael M, et al. J Pathol. 1992 Dec;168(4):371-5. doi: 10.1002/path.1711680406. J Pathol. 1992. PMID: 1484318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page